tert-butyl 4-((6-((4-(benzo[d]thiazol-5-yl)-5-methylpyrimidin-2-yl)amino)pyridin-3-yl)methyl)piperazine-1-carboxylate

ID: ALA5288741

Max Phase: Preclinical

Molecular Formula: C27H31N7O2S

Molecular Weight: 517.66

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cnc(Nc2ccc(CN3CCN(C(=O)OC(C)(C)C)CC3)cn2)nc1-c1ccc2scnc2c1

Standard InChI:  InChI=1S/C27H31N7O2S/c1-18-14-29-25(32-24(18)20-6-7-22-21(13-20)30-17-37-22)31-23-8-5-19(15-28-23)16-33-9-11-34(12-10-33)26(35)36-27(2,3)4/h5-8,13-15,17H,9-12,16H2,1-4H3,(H,28,29,31,32)

Standard InChI Key:  MFEVORGVIUXWPD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   -3.2084    1.0803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2084    0.2553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5004   -0.1681    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5004   -0.9932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7903   -1.4132    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7903   -2.2402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0847   -2.6598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3650   -2.2525    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3468   -2.6696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0641   -2.2621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7755   -2.6777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4951   -2.2693    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4951   -1.4455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2115   -1.0365    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2115   -0.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9270    0.1999    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9270    1.0254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2142    1.4391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2142    2.2641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4987    1.0277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7842    1.4401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7842    2.2651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0698    2.6777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3553    2.2651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4290    2.5200    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9140    1.8526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4290    1.1850    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3553    1.4400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0698    1.0274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4987    0.2022    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7838   -1.0301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0641   -1.4383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3650   -1.4255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0706   -1.0059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2191   -1.3984    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9187    0.6750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9270   -0.1498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 24  1  0
 28 29  2  0
 29 21  1  0
 20 30  2  0
 30 15  1  0
 13 31  1  0
 31 32  2  0
 32 10  1  0
  8 33  1  0
 33 34  1  0
 34  5  1  0
  4 35  2  0
  2 36  1  0
  2 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5288741

    ---

Associated Targets(Human)

DYRK2 Tchem Dual-specificity tyrosine-phosphorylation regulated kinase 2 (2095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 517.66Molecular Weight (Monoisotopic): 517.2260AlogP: 5.25#Rotatable Bonds: 5
Polar Surface Area: 96.37Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.52CX Basic pKa: 5.93CX LogP: 4.92CX LogD: 4.91
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.38Np Likeness Score: -1.70

References

1. Yuan K, Shen H, Zheng M, Xia F, Li Q, Chen W, Ji M, Yang H, Zhuang X, Cai Z, Min W, Wang X, Xiao Y, Yang P..  (2023)  Discovery of Potent DYRK2 Inhibitors with High Selectivity, Great Solubility, and Excellent Safety Properties for the Treatment of Prostate Cancer.,  66  (6): [PMID:36800260] [10.1021/acs.jmedchem.3c00106]

Source